Patent · US Active

Combination therapies for treatment of cancer

US10933134B2 · kind B2 · utility

0Cited by

4References

18Claims

0Family size

Assignees

Memorial Sloan Kettering Cancer Center · US
YEDA RESEARCH & DEVELOPMENT CO LTD. AT THE WEIZMANN INSTITUTE OF SCIENCE · IL

Inventors

Jonathan Coleman · Dublin, IE
Philip Watson · New York, US
Kwanghee KIM · Seoul, KR
Avigdor Scherz · Rehovot, IL

Key dates

Filing date	Mar 16, 2018
Grant date	Mar 2, 2021
Priority date	—
Expiry date	Mar 16, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61N5/062
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for treatment of prostate cancer or benign prostate hyperplasia by combination therapy comprising administering to a patient an androgen-deprivation therapy agent and a bacteriochlorophyll derivative followed by photodynamic therapy (PDT) or vascular-targeted photodynamic therapy (VTP).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.